nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC22A2—Cytarabine—lymphatic system cancer	0.37	0.535	CbGbCtD
Amiloride—SLC22A1—Cytarabine—lymphatic system cancer	0.321	0.465	CbGbCtD
Amiloride—Digestion impaired—Fludarabine—lymphatic system cancer	0.00613	0.0198	CcSEcCtD
Amiloride—Hyperuricaemia—Fludarabine—lymphatic system cancer	0.00441	0.0143	CcSEcCtD
Amiloride—Blood uric acid increased—Fludarabine—lymphatic system cancer	0.00417	0.0135	CcSEcCtD
Amiloride—Encephalopathy—Carmustine—lymphatic system cancer	0.00408	0.0132	CcSEcCtD
Amiloride—Hyperkalaemia—Fludarabine—lymphatic system cancer	0.00402	0.013	CcSEcCtD
Amiloride—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.00387	0.0125	CcSEcCtD
Amiloride—Coma—Fludarabine—lymphatic system cancer	0.00374	0.0121	CcSEcCtD
Amiloride—Depression—Mechlorethamine—lymphatic system cancer	0.00353	0.0114	CcSEcCtD
Amiloride—Jaundice—Mechlorethamine—lymphatic system cancer	0.00345	0.0111	CcSEcCtD
Amiloride—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00319	0.0103	CcSEcCtD
Amiloride—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00317	0.0103	CcSEcCtD
Amiloride—Visual disturbance—Fludarabine—lymphatic system cancer	0.00314	0.0101	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00297	0.00962	CcSEcCtD
Amiloride—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00296	0.00957	CcSEcCtD
Amiloride—Alopecia—Mechlorethamine—lymphatic system cancer	0.0028	0.00907	CcSEcCtD
Amiloride—Neutropenia—Teniposide—lymphatic system cancer	0.00273	0.00884	CcSEcCtD
Amiloride—Hyperuricaemia—Vincristine—lymphatic system cancer	0.0027	0.00873	CcSEcCtD
Amiloride—Neck pain—Carmustine—lymphatic system cancer	0.00265	0.00858	CcSEcCtD
Amiloride—Hyperuricaemia—Mitoxantrone—lymphatic system cancer	0.00263	0.0085	CcSEcCtD
Amiloride—Blood uric acid increased—Vincristine—lymphatic system cancer	0.00255	0.00824	CcSEcCtD
Amiloride—Angina pectoris—Fludarabine—lymphatic system cancer	0.0025	0.0081	CcSEcCtD
Amiloride—Vertigo—Mechlorethamine—lymphatic system cancer	0.00248	0.00803	CcSEcCtD
Amiloride—Blood uric acid increased—Mitoxantrone—lymphatic system cancer	0.00248	0.00803	CcSEcCtD
Amiloride—Dysuria—Fludarabine—lymphatic system cancer	0.0024	0.00777	CcSEcCtD
Amiloride—Neutropenia—Fludarabine—lymphatic system cancer	0.0024	0.00777	CcSEcCtD
Amiloride—Coma—Carmustine—lymphatic system cancer	0.0024	0.00775	CcSEcCtD
Amiloride—Hyperkalaemia—Mitoxantrone—lymphatic system cancer	0.00239	0.00775	CcSEcCtD
Amiloride—Haemoglobin—Teniposide—lymphatic system cancer	0.00235	0.00761	CcSEcCtD
Amiloride—Gynaecomastia—Carmustine—lymphatic system cancer	0.00235	0.00759	CcSEcCtD
Amiloride—Haemorrhage—Teniposide—lymphatic system cancer	0.00234	0.00757	CcSEcCtD
Amiloride—Coma—Vincristine—lymphatic system cancer	0.00229	0.0074	CcSEcCtD
Amiloride—Urine output increased—Vincristine—lymphatic system cancer	0.00226	0.00732	CcSEcCtD
Amiloride—Anorexia—Mechlorethamine—lymphatic system cancer	0.00215	0.00695	CcSEcCtD
Amiloride—Polyuria—Vincristine—lymphatic system cancer	0.00207	0.00669	CcSEcCtD
Amiloride—Alopecia—Teniposide—lymphatic system cancer	0.00207	0.00669	CcSEcCtD
Amiloride—Haemoglobin—Fludarabine—lymphatic system cancer	0.00207	0.00669	CcSEcCtD
Amiloride—Haemorrhage—Fludarabine—lymphatic system cancer	0.00206	0.00665	CcSEcCtD
Amiloride—Visual impairment—Fludarabine—lymphatic system cancer	0.00198	0.00641	CcSEcCtD
Amiloride—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00196	0.00634	CcSEcCtD
Amiloride—Hyponatraemia—Carmustine—lymphatic system cancer	0.00191	0.00618	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.0019	0.00616	CcSEcCtD
Amiloride—Encephalopathy—Methotrexate—lymphatic system cancer	0.00189	0.00612	CcSEcCtD
Amiloride—Hyponatraemia—Vincristine—lymphatic system cancer	0.00182	0.0059	CcSEcCtD
Amiloride—Alopecia—Fludarabine—lymphatic system cancer	0.00182	0.00588	CcSEcCtD
Amiloride—Pain in extremity—Vincristine—lymphatic system cancer	0.00182	0.00588	CcSEcCtD
Amiloride—Liver disorder—Methotrexate—lymphatic system cancer	0.00178	0.00576	CcSEcCtD
Amiloride—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00178	0.00575	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00177	0.00572	CcSEcCtD
Amiloride—Chest pain—Teniposide—lymphatic system cancer	0.00173	0.00561	CcSEcCtD
Amiloride—Muscular weakness—Carmustine—lymphatic system cancer	0.00168	0.00543	CcSEcCtD
Amiloride—Confusional state—Teniposide—lymphatic system cancer	0.00168	0.00542	CcSEcCtD
Amiloride—Muscular weakness—Vincristine—lymphatic system cancer	0.0016	0.00518	CcSEcCtD
Amiloride—Pruritus—Mechlorethamine—lymphatic system cancer	0.0016	0.00516	CcSEcCtD
Amiloride—Anorexia—Teniposide—lymphatic system cancer	0.00158	0.00513	CcSEcCtD
Amiloride—Cough—Fludarabine—lymphatic system cancer	0.00156	0.00505	CcSEcCtD
Amiloride—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00154	0.00499	CcSEcCtD
Amiloride—Neutropenia—Carmustine—lymphatic system cancer	0.00154	0.00497	CcSEcCtD
Amiloride—Arthralgia—Fludarabine—lymphatic system cancer	0.00152	0.00493	CcSEcCtD
Amiloride—Haemoglobin—Bleomycin—lymphatic system cancer	0.00152	0.0049	CcSEcCtD
Amiloride—Haemorrhage—Bleomycin—lymphatic system cancer	0.00151	0.00488	CcSEcCtD
Amiloride—Dyspnoea—Teniposide—lymphatic system cancer	0.00148	0.0048	CcSEcCtD
Amiloride—Confusional state—Fludarabine—lymphatic system cancer	0.00147	0.00477	CcSEcCtD
Amiloride—Dysuria—Vincristine—lymphatic system cancer	0.00147	0.00475	CcSEcCtD
Amiloride—Neutropenia—Vincristine—lymphatic system cancer	0.00147	0.00475	CcSEcCtD
Amiloride—Depression—Carmustine—lymphatic system cancer	0.00146	0.00473	CcSEcCtD
Amiloride—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00145	0.00468	CcSEcCtD
Amiloride—Decreased appetite—Teniposide—lymphatic system cancer	0.00145	0.00468	CcSEcCtD
Amiloride—Vomiting—Mechlorethamine—lymphatic system cancer	0.00143	0.00464	CcSEcCtD
Amiloride—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00143	0.00462	CcSEcCtD
Amiloride—Rash—Mechlorethamine—lymphatic system cancer	0.00142	0.0046	CcSEcCtD
Amiloride—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00142	0.0046	CcSEcCtD
Amiloride—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00141	0.00456	CcSEcCtD
Amiloride—Depression—Vincristine—lymphatic system cancer	0.0014	0.00452	CcSEcCtD
Amiloride—Anorexia—Fludarabine—lymphatic system cancer	0.00139	0.00451	CcSEcCtD
Amiloride—Feeling abnormal—Teniposide—lymphatic system cancer	0.00137	0.00443	CcSEcCtD
Amiloride—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00136	0.0044	CcSEcCtD
Amiloride—Nausea—Mechlorethamine—lymphatic system cancer	0.00134	0.00433	CcSEcCtD
Amiloride—Alopecia—Bleomycin—lymphatic system cancer	0.00133	0.00431	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00133	0.00431	CcSEcCtD
Amiloride—Jaundice—Mitoxantrone—lymphatic system cancer	0.00133	0.0043	CcSEcCtD
Amiloride—Haemoglobin—Carmustine—lymphatic system cancer	0.00132	0.00428	CcSEcCtD
Amiloride—Haemorrhage—Carmustine—lymphatic system cancer	0.00132	0.00426	CcSEcCtD
Amiloride—Abdominal pain—Teniposide—lymphatic system cancer	0.00131	0.00425	CcSEcCtD
Amiloride—Paraesthesia—Fludarabine—lymphatic system cancer	0.00131	0.00424	CcSEcCtD
Amiloride—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.00131	0.00423	CcSEcCtD
Amiloride—Dyspnoea—Fludarabine—lymphatic system cancer	0.0013	0.00421	CcSEcCtD
Amiloride—Dyspepsia—Fludarabine—lymphatic system cancer	0.00129	0.00416	CcSEcCtD
Amiloride—Decreased appetite—Fludarabine—lymphatic system cancer	0.00127	0.00411	CcSEcCtD
Amiloride—Visual impairment—Carmustine—lymphatic system cancer	0.00127	0.0041	CcSEcCtD
Amiloride—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00126	0.00408	CcSEcCtD
Amiloride—Fatigue—Fludarabine—lymphatic system cancer	0.00126	0.00408	CcSEcCtD
Amiloride—Pain—Fludarabine—lymphatic system cancer	0.00125	0.00404	CcSEcCtD
Amiloride—Constipation—Fludarabine—lymphatic system cancer	0.00125	0.00404	CcSEcCtD
Amiloride—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00125	0.00403	CcSEcCtD
Amiloride—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00124	0.004	CcSEcCtD
Amiloride—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00123	0.00398	CcSEcCtD
Amiloride—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00122	0.00396	CcSEcCtD
Amiloride—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0012	0.0039	CcSEcCtD
Amiloride—Asthenia—Teniposide—lymphatic system cancer	0.00119	0.00386	CcSEcCtD
Amiloride—Pruritus—Teniposide—lymphatic system cancer	0.00118	0.00381	CcSEcCtD
Amiloride—Alopecia—Carmustine—lymphatic system cancer	0.00116	0.00376	CcSEcCtD
Amiloride—Cough—Bleomycin—lymphatic system cancer	0.00115	0.00371	CcSEcCtD
Amiloride—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00114	0.00369	CcSEcCtD
Amiloride—Diarrhoea—Teniposide—lymphatic system cancer	0.00114	0.00368	CcSEcCtD
Amiloride—Chest pain—Bleomycin—lymphatic system cancer	0.00112	0.00362	CcSEcCtD
Amiloride—Alopecia—Vincristine—lymphatic system cancer	0.00111	0.00359	CcSEcCtD
Amiloride—Coma—Methotrexate—lymphatic system cancer	0.00111	0.00359	CcSEcCtD
Amiloride—Back pain—Carmustine—lymphatic system cancer	0.00111	0.00359	CcSEcCtD
Amiloride—Urine output increased—Methotrexate—lymphatic system cancer	0.0011	0.00355	CcSEcCtD
Amiloride—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00109	0.00351	CcSEcCtD
Amiloride—Alopecia—Mitoxantrone—lymphatic system cancer	0.00108	0.0035	CcSEcCtD
Amiloride—Confusional state—Bleomycin—lymphatic system cancer	0.00108	0.00349	CcSEcCtD
Amiloride—Tremor—Carmustine—lymphatic system cancer	0.00107	0.00347	CcSEcCtD
Amiloride—Back pain—Vincristine—lymphatic system cancer	0.00106	0.00342	CcSEcCtD
Amiloride—Vomiting—Teniposide—lymphatic system cancer	0.00106	0.00342	CcSEcCtD
Amiloride—Asthenia—Fludarabine—lymphatic system cancer	0.00105	0.00339	CcSEcCtD
Amiloride—Rash—Teniposide—lymphatic system cancer	0.00105	0.00339	CcSEcCtD
Amiloride—Dermatitis—Teniposide—lymphatic system cancer	0.00105	0.00339	CcSEcCtD
Amiloride—Headache—Teniposide—lymphatic system cancer	0.00104	0.00337	CcSEcCtD
Amiloride—Pruritus—Fludarabine—lymphatic system cancer	0.00103	0.00334	CcSEcCtD
Amiloride—Back pain—Mitoxantrone—lymphatic system cancer	0.00103	0.00333	CcSEcCtD
Amiloride—Anorexia—Bleomycin—lymphatic system cancer	0.00102	0.0033	CcSEcCtD
Amiloride—Polyuria—Methotrexate—lymphatic system cancer	0.001	0.00325	CcSEcCtD
Amiloride—Diarrhoea—Fludarabine—lymphatic system cancer	0.001	0.00323	CcSEcCtD
Amiloride—Nausea—Teniposide—lymphatic system cancer	0.000988	0.00319	CcSEcCtD
Amiloride—Vertigo—Vincristine—lymphatic system cancer	0.000983	0.00318	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000976	0.00316	CcSEcCtD
Amiloride—Chest pain—Carmustine—lymphatic system cancer	0.000976	0.00316	CcSEcCtD
Amiloride—Paraesthesia—Bleomycin—lymphatic system cancer	0.000962	0.00311	CcSEcCtD
Amiloride—Dyspnoea—Bleomycin—lymphatic system cancer	0.000955	0.00309	CcSEcCtD
Amiloride—Confusional state—Carmustine—lymphatic system cancer	0.000943	0.00305	CcSEcCtD
Amiloride—Decreased appetite—Bleomycin—lymphatic system cancer	0.000931	0.00301	CcSEcCtD
Amiloride—Visual disturbance—Methotrexate—lymphatic system cancer	0.00093	0.00301	CcSEcCtD
Amiloride—Cough—Mitoxantrone—lymphatic system cancer	0.00093	0.00301	CcSEcCtD
Amiloride—Vomiting—Fludarabine—lymphatic system cancer	0.000929	0.00301	CcSEcCtD
Amiloride—Rash—Fludarabine—lymphatic system cancer	0.000921	0.00298	CcSEcCtD
Amiloride—Dermatitis—Fludarabine—lymphatic system cancer	0.00092	0.00298	CcSEcCtD
Amiloride—Pain—Bleomycin—lymphatic system cancer	0.000916	0.00296	CcSEcCtD
Amiloride—Headache—Fludarabine—lymphatic system cancer	0.000915	0.00296	CcSEcCtD
Amiloride—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000907	0.00293	CcSEcCtD
Amiloride—Chest pain—Mitoxantrone—lymphatic system cancer	0.000907	0.00293	CcSEcCtD
Amiloride—Anorexia—Carmustine—lymphatic system cancer	0.000891	0.00288	CcSEcCtD
Amiloride—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000883	0.00286	CcSEcCtD
Amiloride—Confusional state—Mitoxantrone—lymphatic system cancer	0.000877	0.00284	CcSEcCtD
Amiloride—Nausea—Fludarabine—lymphatic system cancer	0.000868	0.00281	CcSEcCtD
Amiloride—Shock—Mitoxantrone—lymphatic system cancer	0.000855	0.00277	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000852	0.00276	CcSEcCtD
Amiloride—Anorexia—Vincristine—lymphatic system cancer	0.000851	0.00275	CcSEcCtD
Amiloride—Insomnia—Carmustine—lymphatic system cancer	0.000846	0.00274	CcSEcCtD
Amiloride—Paraesthesia—Carmustine—lymphatic system cancer	0.00084	0.00272	CcSEcCtD
Amiloride—Dyspnoea—Carmustine—lymphatic system cancer	0.000834	0.0027	CcSEcCtD
Amiloride—Somnolence—Carmustine—lymphatic system cancer	0.000831	0.00269	CcSEcCtD
Amiloride—Anorexia—Mitoxantrone—lymphatic system cancer	0.000829	0.00268	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000813	0.00263	CcSEcCtD
Amiloride—Decreased appetite—Carmustine—lymphatic system cancer	0.000813	0.00263	CcSEcCtD
Amiloride—Insomnia—Vincristine—lymphatic system cancer	0.000807	0.00261	CcSEcCtD
Amiloride—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000807	0.00261	CcSEcCtD
Amiloride—Paraesthesia—Vincristine—lymphatic system cancer	0.000802	0.00259	CcSEcCtD
Amiloride—Pain—Carmustine—lymphatic system cancer	0.0008	0.00259	CcSEcCtD
Amiloride—Constipation—Carmustine—lymphatic system cancer	0.0008	0.00259	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000792	0.00256	CcSEcCtD
Amiloride—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000781	0.00253	CcSEcCtD
Amiloride—Decreased appetite—Vincristine—lymphatic system cancer	0.000776	0.00251	CcSEcCtD
Amiloride—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000775	0.00251	CcSEcCtD
Amiloride—Somnolence—Mitoxantrone—lymphatic system cancer	0.000773	0.0025	CcSEcCtD
Amiloride—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000771	0.00249	CcSEcCtD
Amiloride—Feeling abnormal—Carmustine—lymphatic system cancer	0.000771	0.00249	CcSEcCtD
Amiloride—Fatigue—Vincristine—lymphatic system cancer	0.00077	0.00249	CcSEcCtD
Amiloride—Asthenia—Bleomycin—lymphatic system cancer	0.000769	0.00249	CcSEcCtD
Amiloride—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000765	0.00248	CcSEcCtD
Amiloride—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000765	0.00247	CcSEcCtD
Amiloride—Pain—Vincristine—lymphatic system cancer	0.000763	0.00247	CcSEcCtD
Amiloride—Constipation—Vincristine—lymphatic system cancer	0.000763	0.00247	CcSEcCtD
Amiloride—Pruritus—Bleomycin—lymphatic system cancer	0.000758	0.00245	CcSEcCtD
Amiloride—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000756	0.00244	CcSEcCtD
Amiloride—Fatigue—Mitoxantrone—lymphatic system cancer	0.00075	0.00242	CcSEcCtD
Amiloride—Pain—Mitoxantrone—lymphatic system cancer	0.000743	0.00241	CcSEcCtD
Amiloride—Constipation—Mitoxantrone—lymphatic system cancer	0.000743	0.00241	CcSEcCtD
Amiloride—Abdominal pain—Carmustine—lymphatic system cancer	0.000739	0.00239	CcSEcCtD
Amiloride—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00073	0.00236	CcSEcCtD
Amiloride—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000716	0.00232	CcSEcCtD
Amiloride—Dysuria—Methotrexate—lymphatic system cancer	0.000712	0.0023	CcSEcCtD
Amiloride—Neutropenia—Methotrexate—lymphatic system cancer	0.000712	0.0023	CcSEcCtD
Amiloride—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000711	0.0023	CcSEcCtD
Amiloride—Abdominal pain—Vincristine—lymphatic system cancer	0.000706	0.00228	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000702	0.00227	CcSEcCtD
Amiloride—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000687	0.00222	CcSEcCtD
Amiloride—Vomiting—Bleomycin—lymphatic system cancer	0.000681	0.0022	CcSEcCtD
Amiloride—Depression—Methotrexate—lymphatic system cancer	0.000677	0.00219	CcSEcCtD
Amiloride—Rash—Bleomycin—lymphatic system cancer	0.000676	0.00219	CcSEcCtD
Amiloride—Dermatitis—Bleomycin—lymphatic system cancer	0.000675	0.00218	CcSEcCtD
Amiloride—Asthenia—Carmustine—lymphatic system cancer	0.000671	0.00217	CcSEcCtD
Amiloride—Asthenia—Vincristine—lymphatic system cancer	0.000641	0.00207	CcSEcCtD
Amiloride—Diarrhoea—Carmustine—lymphatic system cancer	0.00064	0.00207	CcSEcCtD
Amiloride—Nausea—Bleomycin—lymphatic system cancer	0.000636	0.00206	CcSEcCtD
Amiloride—Asthenia—Mitoxantrone—lymphatic system cancer	0.000624	0.00202	CcSEcCtD
Amiloride—Dizziness—Carmustine—lymphatic system cancer	0.000618	0.002	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—lymphatic system cancer	0.000613	0.00198	CcSEcCtD
Amiloride—Diarrhoea—Vincristine—lymphatic system cancer	0.000611	0.00198	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—lymphatic system cancer	0.00061	0.00197	CcSEcCtD
Amiloride—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000595	0.00192	CcSEcCtD
Amiloride—Vomiting—Carmustine—lymphatic system cancer	0.000595	0.00192	CcSEcCtD
Amiloride—Dizziness—Vincristine—lymphatic system cancer	0.00059	0.00191	CcSEcCtD
Amiloride—Rash—Carmustine—lymphatic system cancer	0.00059	0.00191	CcSEcCtD
Amiloride—Dermatitis—Carmustine—lymphatic system cancer	0.000589	0.00191	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—lymphatic system cancer	0.000588	0.0019	CcSEcCtD
Amiloride—Headache—Carmustine—lymphatic system cancer	0.000586	0.0019	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—lymphatic system cancer	0.000568	0.00184	CcSEcCtD
Amiloride—Vomiting—Vincristine—lymphatic system cancer	0.000568	0.00184	CcSEcCtD
Amiloride—Rash—Vincristine—lymphatic system cancer	0.000563	0.00182	CcSEcCtD
Amiloride—Dermatitis—Vincristine—lymphatic system cancer	0.000562	0.00182	CcSEcCtD
Amiloride—Headache—Vincristine—lymphatic system cancer	0.000559	0.00181	CcSEcCtD
Amiloride—Nausea—Carmustine—lymphatic system cancer	0.000555	0.0018	CcSEcCtD
Amiloride—Vomiting—Mitoxantrone—lymphatic system cancer	0.000553	0.00179	CcSEcCtD
Amiloride—Rash—Mitoxantrone—lymphatic system cancer	0.000548	0.00177	CcSEcCtD
Amiloride—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000548	0.00177	CcSEcCtD
Amiloride—Headache—Mitoxantrone—lymphatic system cancer	0.000545	0.00176	CcSEcCtD
Amiloride—Alopecia—Methotrexate—lymphatic system cancer	0.000539	0.00174	CcSEcCtD
Amiloride—Nausea—Vincristine—lymphatic system cancer	0.00053	0.00172	CcSEcCtD
Amiloride—Nausea—Mitoxantrone—lymphatic system cancer	0.000516	0.00167	CcSEcCtD
Amiloride—Back pain—Methotrexate—lymphatic system cancer	0.000513	0.00166	CcSEcCtD
Amiloride—Vertigo—Methotrexate—lymphatic system cancer	0.000477	0.00154	CcSEcCtD
Amiloride—Cough—Methotrexate—lymphatic system cancer	0.000463	0.0015	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—lymphatic system cancer	0.000452	0.00146	CcSEcCtD
Amiloride—Chest pain—Methotrexate—lymphatic system cancer	0.000452	0.00146	CcSEcCtD
Amiloride—Confusional state—Methotrexate—lymphatic system cancer	0.000437	0.00141	CcSEcCtD
Amiloride—Anorexia—Methotrexate—lymphatic system cancer	0.000413	0.00134	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000395	0.00128	CcSEcCtD
Amiloride—Insomnia—Methotrexate—lymphatic system cancer	0.000392	0.00127	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—lymphatic system cancer	0.000389	0.00126	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—lymphatic system cancer	0.000386	0.00125	CcSEcCtD
Amiloride—Somnolence—Methotrexate—lymphatic system cancer	0.000385	0.00125	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—lymphatic system cancer	0.000381	0.00123	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—lymphatic system cancer	0.000377	0.00122	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000374	0.00121	CcSEcCtD
Amiloride—Fatigue—Methotrexate—lymphatic system cancer	0.000373	0.00121	CcSEcCtD
Amiloride—Pain—Methotrexate—lymphatic system cancer	0.00037	0.0012	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000357	0.00115	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000354	0.00115	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—lymphatic system cancer	0.000342	0.00111	CcSEcCtD
Amiloride—Asthenia—Methotrexate—lymphatic system cancer	0.000311	0.00101	CcSEcCtD
Amiloride—Pruritus—Methotrexate—lymphatic system cancer	0.000306	0.000991	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—lymphatic system cancer	0.000296	0.000959	CcSEcCtD
Amiloride—Dizziness—Methotrexate—lymphatic system cancer	0.000286	0.000927	CcSEcCtD
Amiloride—Vomiting—Methotrexate—lymphatic system cancer	0.000275	0.000891	CcSEcCtD
Amiloride—Rash—Methotrexate—lymphatic system cancer	0.000273	0.000884	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—lymphatic system cancer	0.000273	0.000883	CcSEcCtD
Amiloride—Headache—Methotrexate—lymphatic system cancer	0.000271	0.000878	CcSEcCtD
Amiloride—Nausea—Methotrexate—lymphatic system cancer	0.000257	0.000832	CcSEcCtD
